We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $10.2M invested in Seelos Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,900% more call options, than puts

Call options by funds: $60K | Put options by funds: $3K

9% more capital invested

Capital invested by funds: $9.4M → $10.2M (+$808K)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
$60K
Puts
$3K
Net Calls
+$57K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
+$8.6M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$15K
2
Citadel Advisors
Citadel Advisors
Florida
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$8.41M +$8.6M +7 +117%
Vanguard Group
2
Vanguard Group
Pennsylvania
$872K – – –
HVC
3
Healthcare Value Capital
New Jersey
$256K – – –
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$150K – – –
BFA
5
BlackRock Fund Advisors
California
$73K – – –
Franklin Resources
6
Franklin Resources
California
$60K – – –
Northern Trust
7
Northern Trust
Illinois
$51K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$42K – – –
HighTower Advisors
9
HighTower Advisors
Illinois
$35K – – –
BIT
10
BlackRock Institutional Trust
California
$34K – – –
CC
11
Callan Capital
California
$32K – – –
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$32K – – –
TSS
13
Two Sigma Securities
New York
$19K – – –
Bank of America
14
Bank of America
North Carolina
$15K – – –
MBA
15
McQueen Ball & Associates
Pennsylvania
$15K – – –
UBS Group
16
UBS Group
Switzerland
$13K – – –
LPL Financial
17
LPL Financial
California
$12K – – –
GC
18
Guggenheim Capital
Illinois
$11K – – –
Group One Trading
19
Group One Trading
Illinois
$10K – – –
Morgan Stanley
20
Morgan Stanley
New York
$9K – – –
Creative Planning
21
Creative Planning
Kansas
$8K – – –
BA
22
BlackRock Advisors
Delaware
$7K – – –
BIM
23
BlackRock Investment Management
Delaware
$6K – – –
FANJ
24
Financial Architects (New Jersey)
New Jersey
$6K – – –
State Street
25
State Street
Massachusetts
$6K – – –
1
2

SEEL Hedge Fund Activity: Q1 2016 in Review

2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2016, worth a combined $10.2M — up 8.6% from $9.4M a quarter earlier.

Fund positioning in SEEL was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Sarissa Capital Management, adding an estimated $8.6M. The largest seller was Goldman Sachs, cutting an estimated $15K.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $10.2M of Seelos Therapeutics, Inc. Common Stock stock for Q1 2016, up 8.6% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2016 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q1 2016 was Sarissa Capital Management, an estimated $8.6M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2016 was Goldman Sachs, an estimated $15K sold.

Based on aggregated 13F filings for Q1 2016.